Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00828490 · ClinicalTrials.gov registry record

Electronic Pharmacotherapy Risk Management

A clinical trial, sponsored by University of Utah.

Completed
Registry status
174,000
Enrollment target

NCT00828490: Completed study, sponsored by University of Utah.

NCT00828490 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 174,000 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00828490 has completed, sponsored by University of Utah.

COMPLETED
Registry status
174,000 participants
Enrollment target

Study Summary

The purpose of the Utah ePRM (electronic Pharmacotherapy Risk Management) project is to improve quality and safety of medication use while simultaneously controlling costs and detecting fraud and abuse.

Interventions

  • BEHAVIORAL provider feedback
  • BEHAVIORAL patient intervention
  • BEHAVIORAL Process-level

Trial Details

FieldValue
Enrollment Target 174,000 participants
Start Date 2007-07
Est. Completion 2010-03
University of Utah

818 total trials

What the finished NCT00828490 record still lists

NCT00828490 is an observational study that tracks outcomes without assigning an intervention. Its 174,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 3 interventions - of which provider feedback is the first listed.

NCT00828490 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00828490 about?

NCT00828490 is a clinical study titled "Electronic Pharmacotherapy Risk Management". The purpose of the Utah ePRM (electronic Pharmacotherapy Risk Management) project is to improve quality and safety of medication use while simultaneously controlling costs and detecting fraud and abuse.

What is the current status of trial NCT00828490?

This trial is currently completed. The enrollment target is 174,000 participants. The study started on 2007-07. Estimated completion is 2010-03.

What interventions are being tested in trial NCT00828490?

The interventions under investigation include: provider feedback (BEHAVIORAL), patient intervention (BEHAVIORAL), Process-level (BEHAVIORAL).

Who is sponsoring clinical trial NCT00828490?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06090578 · 180,000 participants · NA

    TabCAT Brain Health Assessment in Primary Care

  • NCT06917339 · 156,000 participants

    Retrospective Analyses of TrakStar Database

  • NCT06232551 · 152,000 participants · NA

    Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism

  • NCT05994482 · 130,000 participants

    Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00828490, the US trial registry maintained by the National Library of Medicine. NCT00828490 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.